Pseudoneutropenia in lymphangioleiomyomatosis (LAM) patients receiving sirolimus: evaluation in a 100 patient cohort.
Vissagan GopalakrishnanAmanda M JonesPatricia Julien-WilliamsTania MachadoRobert L DannerJeffrey J SwigrisRobert PaineJay N LozierJoel MossPublished in: ERJ open research (2018)
In lymphangioleiomyomatosis patients receiving sirolimus treatment, transient leukopenia in the morning may be due to circadian rhythm, with leukocyte counts recovering later in the day, indicating that a decrease in drug dose may not be warranted http://ow.ly/jPFz30iysgV.